Kingworld Medicines Group Limited

1110.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1110.HK stands at 294.8M. In comparison, 0241.HK has a market cap of 77.1B. Regarding current trading prices, 1110.HK is priced at HK$0.50, while 0241.HK trades at HK$4.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1110.HK currently has a P/E ratio of 50.00, whereas 0241.HK's P/E ratio is 34.14. In terms of profitability, 1110.HK's ROE is +0.01%, compared to 0241.HK's ROE of +0.14%. Regarding short-term risk, 1110.HK is less volatile compared to 0241.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1110.HK.Check 0241.HK's competition here

1110.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1110.HK stands at 294.8M. In comparison, 3613.HK has a market cap of 6.5B. Regarding current trading prices, 1110.HK is priced at HK$0.50, while 3613.HK trades at HK$7.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1110.HK currently has a P/E ratio of 50.00, whereas 3613.HK's P/E ratio is 16.40. In terms of profitability, 1110.HK's ROE is +0.01%, compared to 3613.HK's ROE of +0.13%. Regarding short-term risk, 1110.HK is less volatile compared to 3613.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1110.HK.Check 3613.HK's competition here

1110.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1110.HK stands at 294.8M. In comparison, 1345.HK has a market cap of 2.6B. Regarding current trading prices, 1110.HK is priced at HK$0.50, while 1345.HK trades at HK$2.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1110.HK currently has a P/E ratio of 50.00, whereas 1345.HK's P/E ratio is 22.70. In terms of profitability, 1110.HK's ROE is +0.01%, compared to 1345.HK's ROE of +0.10%. Regarding short-term risk, 1110.HK is less volatile compared to 1345.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1110.HK.Check 1345.HK's competition here

1110.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1110.HK stands at 294.8M. In comparison, 3390.HK has a market cap of 236.9M. Regarding current trading prices, 1110.HK is priced at HK$0.50, while 3390.HK trades at HK$0.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1110.HK currently has a P/E ratio of 50.00, whereas 3390.HK's P/E ratio is -6.62. In terms of profitability, 1110.HK's ROE is +0.01%, compared to 3390.HK's ROE of -0.05%. Regarding short-term risk, 1110.HK is less volatile compared to 3390.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1110.HK.Check 3390.HK's competition here

1110.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1110.HK stands at 294.8M. In comparison, 0348.HK has a market cap of 70.9M. Regarding current trading prices, 1110.HK is priced at HK$0.50, while 0348.HK trades at HK$0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1110.HK currently has a P/E ratio of 50.00, whereas 0348.HK's P/E ratio is -9.20. In terms of profitability, 1110.HK's ROE is +0.01%, compared to 0348.HK's ROE of +0.58%. Regarding short-term risk, 1110.HK is less volatile compared to 0348.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1110.HK.Check 0348.HK's competition here

1110.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1110.HK stands at 294.8M. In comparison, 0574.HK has a market cap of 63.4M. Regarding current trading prices, 1110.HK is priced at HK$0.50, while 0574.HK trades at HK$0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1110.HK currently has a P/E ratio of 50.00, whereas 0574.HK's P/E ratio is -1.07. In terms of profitability, 1110.HK's ROE is +0.01%, compared to 0574.HK's ROE of +0.42%. Regarding short-term risk, 1110.HK is less volatile compared to 0574.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1110.HK.Check 0574.HK's competition here

1110.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1110.HK stands at 294.8M. In comparison, 2211.HK has a market cap of 47.9M. Regarding current trading prices, 1110.HK is priced at HK$0.50, while 2211.HK trades at HK$0.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1110.HK currently has a P/E ratio of 50.00, whereas 2211.HK's P/E ratio is -1.64. In terms of profitability, 1110.HK's ROE is +0.01%, compared to 2211.HK's ROE of -0.08%. Regarding short-term risk, 1110.HK is less volatile compared to 2211.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1110.HK.Check 2211.HK's competition here